Affimed NV (AFMD)

[stocktrademan]

$AFMD recent news/filings

bullish

## source: finance.yahoo.com

Fri, 29 May 2015 09:34:01 GMT ~ Affimed ASCO Data Demonstrate Consistent Potency of NKCell- Engaging Combination Therapy with Checkpoint Modulators

[at noodls] - FOR IMMEDIATE RELEASE Affimed ASCO Data Demonstrate Consistent Potency of NK- Cell-Engaging Combination Therapy with Checkpoint Modulators --Affimed's lead NK-cell engager AFM13 shows highly synergistic ...

read full: http://www.noodls.com/view/0540FFACD1E397FA384BF468BCD28DBAD60D59E4
*********************************************************

Fri, 29 May 2015 09:34:01 GMT ~ Affimed ASCO Data for the CD33/CD3-TandAb Program Demonstrate that CD33 and CD3 binding affinities correlate with potent T-cell activation and cytotoxicity

[at noodls] - FOR IMMEDIATE RELEASE -- TandAb platform enables reliable and rapid candidate selection -- Heidelberg, Germany, May 29, 2015 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused ...

read full: http://www.noodls.com/view/830DAF67A8F086FEE3DF2921A4E835E8A151B78E
*********************************************************

Fri, 29 May 2015 09:16:00 GMT ~ 5:16 am Affimed Therapeutics' lead NK-cell engager AFM13 shows highly synergistic efficacy with PD-1 inhibitor


read full: http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#afmd
*********************************************************

Fri, 29 May 2015 09:00:00 GMT ~ Affimed ASCO Data for the CD33/CD3-TandAb Program Demonstrate that CD33 and CD3 Binding Affinities Correlate with Potent T-cell Activation and Cytotoxicity

[GlobeNewswire] - HEIDELBERG, Germany -- Affimed N.V. , a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies based on its proprietary TandAb platform, today ...

read full: http://finance.yahoo.com/news/affimed-asco-data-cd33-cd3-090000884.html
*********************************************************

Fri, 29 May 2015 09:00:00 GMT ~ Affimed ASCO Data Demonstrate Consistent Potency of NK-Cell-Engaging Combination Therapy with Checkpoint Modulators

[GlobeNewswire] - HEIDELBERG, Germany -- Affimed N.V. , a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today provided details on preclinical data ...

read full: http://finance.yahoo.com/news/affimed-asco-data-demonstrate-consistent-090000605.html
*********************************************************

$AFMD charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$AFMD company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/AFMD/company-info
Ticker: $AFMD
OTC Market Place: Not Available
CIK code: not found
Company name: Affimed N.V.
Incorporated In:
$AFMD share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

$AFMD extra dd links

Company name: Affimed N.V.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/AFMD/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/AFMD/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=AFMD+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=AFMD+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=AFMD+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/AFMD/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/AFMD/news - http://finance.yahoo.com/q/h?s=AFMD+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/AFMD/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/AFMD/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/AFMD/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/AFMD/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/AFMD/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/AFMD/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/AFMD/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/AFMD/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=AFMD+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/AFMD
DTCC (dtcc.com): http://search2.dtcc.com/?q=Affimed+N.V.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Affimed+N.V.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Affimed+N.V.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/AFMD/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/AFMD
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/AFMD/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/AFMD/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/AFMD/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/AFMD/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/AFMD/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/AFMD/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/AFMD/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=AFMD&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=AFMD
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/AFMD/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=AFMD+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=AFMD+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=AFMD
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=AFMD
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=AFMD+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/AFMD/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=AFMD+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/AFMD.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=AFMD
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/AFMD/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/AFMD/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/AFMD/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/AFMD/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/AFMD
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/AFMD
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/AFMD:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=AFMD
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=AFMD



$AFMD DD Notes ~ http://www.ddnotesmaker.com/AFMD